Ah, the stock market. A bastion of rational thought, predictable trends, and calm, measured reactions. Or, at least, that’s what the textbooks tell us. In the era of Donald J. Trump, however, the market often resembles a particularly caffeinated squirrel navigating a minefield of Truth Social posts and impromptu policy pronouncements. Investors, it seems, have learned to strap in, brace for impact, and perhaps keep a bottle of antacids handy. The latest round of tariff threats, trade talks, and pharmaceutic ...

BRIDGEWATER, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, today announced that the Company will release its third quarter 2025 financial results on Thursday, October 30, 2025, prior to market open. The Company will host an audio webcast at 8:30 a.m. ET. The financial results and live webcast will be accessible through the Investor Relations section of the Company's website at https://investors.amneal.com ...

The major U.S. index futures are currently pointing to a higher open on Monday, with stocks likely to extend the upward move seen over the course of last Friday's session.The may benefit from resumed strength among artificial intelligence stocks, which helped lead a pullback in the middle of last week.Shares of AI darling and market leader Nvidia (NVDA) are jumping by 1.0 percent in pre-market trading, while shares of Oracle (ORCL) are climbing by 0.9 percent after moving sharply lower over the past severa ...

North Chicago, Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells healthcare products. Valued at $232.4 billion by market cap, ABT is a global leader in the large and growing in-vitro diagnostic market, and its products include pharmaceuticals, nutritional, diagnostics, and vascular products. The medical device manufacturer is expected to announce its fiscal third-quarter earnings for 2025 before the market opens on Wednesday, Oct. 15. Ahead of the event, analysts expect ...

President Donald Trump is taking further aim at America’s reliance on foreign partners, which his senior counselor on trade claims is designed to shift supply chains domestically and end China’s grip on the U.S. "I had a situation where a Chinese company gets approval for an antibiotic at the FDA, gives a bunch of money to an Indian company, and then the Indian company fronts to get a contract at the VA that pushes out an American maker. So those are the kinds of things we're having to deal with, and that's ...

Take a Trial Today Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20! IBD Videos BREAKING: Bullish Rebound Pares Market's Weekly Losses President Donald Trump on Thursday night announced a fresh wave of tariffs set to launch Oct. 1 taxing imports of heavy trucks, furniture and pharmaceuticals, citing national security purposes. Stocks were mixed, as some domestic manufacturers rose, while higher-end importers, including RH (RH) f ...

I first want to start our discussion with the latest trade tariffs announced by President Trump. Uh we got 100% on pharmaceuticals, 25% on heavy trucks. Then there's kitchen cabinets and upholstered furniture.What do you make of this latest move. >> Well, all of these are are considered part of section 232 national security tariffs. They have been rumored for a while, especially the pharmaceutical one has been lined up for quite some time.those cabinets and furniture uh tariffs are part of an ongoing lumber ...

A look at the day ahead in European and global markets from Rae Wee Just as the word was slowly fading away from the memories of investors, it has been foisted upon them again. Asian share markets slumped on Friday after U.S. President Donald Trump made his latest tariff salvo, and attention now turns to Europe. Trump on Thursday unveiled punishing tariffs on a broad range of imported goods, including 100% duties on branded drugs and 25% tariffs on heavy-duty trucks, set to take effect from October 1. H ...

US President Donald Trump's latest executive actions and trade moves sent global markets reeling on Friday. From new tariffs on pharmaceuticals, furniture, and heavy trucks to a TikTok US divestiture ... ...

By Isla Binnie NEW YORK (Reuters) -Gains in Wall Street indexes on Friday were not enough to erase a loss for the week while resilient consumer spending supported longer-dated Treasury yields and gold rose as a steady inflation reading supported bets on future Federal Reserve rate cuts. Consumer spending climbed slightly more than expected in August while the inflation rate rose to 2.7% from 2.6% in July, data showed, in line with economists' expectations. Analysts said some companies had fended off pri ...